Wolfgang Miesbach/LinkedIn
May 13, 2026, 15:10
Wolfgang Miesbach: Rethinking Bleeding Risk in Anticoagulation
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Rethinking Bleeding Risk in Anticoagulation.
At the EHA‑SWG Scientific Meeting on Bleeding and Platelet Disorders, Mariantonietta Tripodo delivered a fantastic talk on bleeding risk in patients receiving antithrombotic therapy – from AF and VTE to prosthetic valves, LV thrombus and acute coronary syndromes:
- Antithrombotic therapy is used across many indications, so managing bleeding risk is a daily challenge in routine practice.
- Major bleeding (incl. ICH) remains a major limitation of VKAs and DOACs, and ‘fear‑driven’ underdosing in real life is still common.
- High‑risk patients (age, renal impairment, prior bleeding) live within a narrow therapeutic window, making individualized decisions essential.
- Targeting FXI could help decouple thrombosis from hemostasis, with early data suggesting relevant bleeding reduction while preserving efficacy.”
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Jun 10, 2026, 16:48Maha Othman: How Artificial Intelligence and Machine Learning Can Improve Risk Assessment of Cancer-Associated Thrombosis
-
Jun 10, 2026, 15:41Maxime Dely: Did You Know That A Single Platelet Donation Can Help Two Patients?
-
Jun 10, 2026, 15:37Wolfgang Miesbach: Why B-Cell Depletion Is Not Always Enough in Immune Thrombocytopenia
-
Jun 10, 2026, 15:30Shadi Tabibian: Living With Unexplained Bleeding – Insights From the Vienna Bleeding Biobank
-
Jun 10, 2026, 15:27Siddharth Mittal: Transfusion Medicine as the Gateway to Cell and Gene Therapy
-
Jun 10, 2026, 15:23Jonathan Douxfils: New Data on Hemostasis, VTE, and Breast Cancer to Rethink the Reference Standard
-
Jun 10, 2026, 15:16Rena Hirani: The Role of Paper Substrates and Storage Conditions
-
Jun 10, 2026, 15:06Ashkan Golshani: Congratulations to Our Team on Recent Publications in Molecular Biology and AI-Driven Research
-
Jun 10, 2026, 14:52David Ferreira: Standardizing Thrombin Generation Testing in Portugal and Spain